BioSpace News Archive

Policy

Former Insys Executive Found Guilty for Opioid Marketing Schemes Sentenced to 33 Months

The first of the Insys Therapeutics executives found guilty of violating the Racketeer Influenced and Corrupt Organizations Act in May 2019 has been sentenced.

January 16, 2020
·
4 min read
·
Alex Keown
Career Advice

Preparing for Behavioral Interviews with the STAR Method

When using the STAR Method, be sure to discuss the who, what, where, when and how of an experience.

January 16, 2020
·
2 min read
·
Porschia Parker
Business

BioSpace Movers & Shakers, Jan. 17

Pharma companies add new members to executive ranks and boards of directors.

January 16, 2020
·
6 min read
·
Alex Keown
FDA

The FDA Approves Drugs Faster, But That Might Not Be A Good Thing

Investigators found that the U.S. Food and Drug Administration is approving drugs faster than ever. Unfortunately, it appears that the agency is also approving those drugs on less data and weaker evidence.

January 16, 2020
·
4 min read
·
Mark Terry
BioCapital

Who are the 10 Most Innovative Biopharma Companies?

Here’s a look at the top 10 companies noted in the BioSpace Ideal Employer 2019 survey for being the most innovative and what they’ve been up to recently.

January 16, 2020
·
7 min read
·
Mark Terry
Business

ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule

ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate..

January 16, 2020
·
2 min read
Business

Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

January 16, 2020
·
5 min read
Business

Patient-Data Platform Raremark Enhances Executive Team to Accelerate Progress in Rare Disease Research

Raremark, the leading patient-data platform in rare disease, is pleased to announce additions to its executive team to speed the company’s pursuit of more treatments for rare medical conditions.

January 16, 2020
·
3 min read
Biotech Bay

Asia-Pacific has Record Year for Clinical Trials according to Novotech

Novotech, the largest biotech CRO in Asia Pacific, says the region has had a record year by number of studies, experienced world-class sites and investigators, and patient enrollment.

January 16, 2020
·
3 min read
Deals

DLA Piper advises Osceola Capital in its acquisition of Healthcents

DLA Piper is pleased to announce that the firm represented Osceola Capital, a middle-market private equity firm focused on services businesses, in its acquisition of Healthcents, Inc., a leading provider of medical reimbursement and related services.

January 16, 2020
·
2 min read